- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
Fidelity Advisor Biotechnology Fund
+ Add to WatchlistFBTTX:US
14.23 USD 0.14 0.97%As of 09:29:30 ET on 06/17/2013.
Snapshot for Fidelity Advisor Biotechnology Fund (FBTTX)
| Year To Date: | +27.51% | 3-Month: | +9.88% | 3-Year: | +31.27% | 52-Week Range: | 10.10 - 15.11 |
|---|---|---|---|---|---|---|---|
| 1-Month: | -4.18% | 1-Year: | +42.17% | 5-Year: | +17.35% | Beta vs MXWO: | 0.90 |
Fund Profile & Information for FBTTX
Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.
| Inception Date: | 12-27-2000 | Telephone: | 1-877-208-0098 |
|---|---|---|---|
| Managers: | RAJIV KAUL | ||
| Web Site: | advisor.fidelity.com | ||
Fundamentals for FBTTX
| NAV | (on 2013-06-17) 14.23 |
|---|---|
| Assets (M) | (on 2013-05-31) 505.67 |
| Fund Leveraged | N |
| Minimum Investment | 2,500.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for FBTTX
| Dividend Type | Omitted |
|---|---|
| Dividend Frequency | Semi-Anl |
| Last Dividend Net | - |
| Dividend Yield (ttm) | 4.81 |
Fees & Expenses for FBTTX
| Front Load | 3.50 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.56 |
| Redemption Fee | 0.75 |
| 12b1 Fee | 0.50 |
| Expense Ratio | 1.56 |
Top Fund Holdings for FBTTX
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Amgen Inc | 619,514 | 64,559,554 | 14.950% |
| Gilead Sciences Inc | 1,205,794 | 61,061,408 | 14.140% |
| Celgene Corp | 274,183 | 32,372,787 | 7.497% |
| Biogen Idec Inc | 135,526 | 29,670,707 | 6.871% |
| Alexion Pharmaceuticals Inc | 238,563 | 23,379,174 | 5.414% |
| Regeneron Pharmaceuticals Inc | 92,204 | 19,836,769 | 4.594% |
| Vertex Pharmaceuticals Inc | 255,373 | 19,617,754 | 4.543% |
| BioMarin Pharmaceutical Inc | 165,738 | 10,872,413 | 2.518% |
| Onyx Pharmaceuticals Inc | 102,168 | 9,685,526 | 2.243% |
| Medivation Inc | 156,948 | 8,272,729 | 1.916% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page